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Patterns and Predictors of HosPital readmission in taiwan
Cheng J.S.1, Ku H.P.1, Chang C.J.2
1Chang Gung University, Tao-Yuan, Taiwan, 2Chang Gung University, Kwei Shan, Tao Yuan, 
Taiwan
Objectives: Hospital readmissions have been an important issue, as they reflect 
suboptimal quality of medical care and incur high health care expenditures. 
However, limited information is available on the patterns of hospital readmission 
in the entire population to support a thorough planning to prevent hospital readmis-
sions. Therefore, this study aimed to examine the patterns and economic burden 
of hospital readmission in Taiwan, and identify predictors of hospital readmis-
sions. MethOds: This study used the National Health Insurance Research Database 
of enrollees randomly selected from those enrolled in the National Health Insurance 
program in 2005. Individuals who were admitted to acute hospitals in 2005 were 
selected and their readmission patterns one-year after discharge were examined. 
Cox proportional hazards regression model was adopted to identify predictors of 
hospital readmission. Results: The 30-day, 6-month and one-year readmission 
rates were 11%, 25%, and 34%, respectively. During the one-year follow-up, 52% of 
total health care expenditures were due to hospital readmissions. Of those who 
were readmitted to hospitals, 56% were readmitted once and took up 29% of the 
cost of rehospitalization. However, those readmitted for more than three times (5%) 
accounted for 30% of the cost. The major disease category of the highest 30-day and 
one-year readmission rates was neoplasms. The disease of the highest 30-day and 
one-year readmission rates were cancer of bronchus and lung (36%) and cancer of 
liver and intrahepatic bile duct (74%), respectively, and the most frequent reason 
for readmission was the disease itself. Age, gender, place of residence, previous 
hospitalization history, comorbidities, and length of stay of the index hospitalization 
were risk factors of hospital readmissions. cOnclusiOns: This study identified 
diseases of higher short-term and long-term readmission rates, causes of short-
term and long-term hospital readmissions, and predictors of hospital readmission. 
The information is of importance for planning interventions to reduce hospital 
readmission rate.
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secure system for iv administrations: HealtH economic imPact of a 
“smart” infusion safety system
Schmidt A., Bénard S.
st[è]ve consultants, Oullins, France
Objectives: More than half of medication errors are reported during admin-
istration. “Smart” Infusion Safety Systems (SISS) have been developed to avoid 
administration errors and provide data for continuous quality improvement (CQI). 
Few data produced by SISS have been analysed. Given the lack of clinical trials, a 
model was developed in order to assess the economic benefits of SISS from the 
perspective of a French public hospital. MethOds: Comprehensive data from 
6 intensive care units (ICU) were analysed. Two types of alerts were defined: hard 
(absolute) and soft limits. An avoided error was defined as the detection of a 
scheduled infusion over a hard limit or a scheduled infusion over a soft limit that 
was later overridden by staff. The severity of consequences was estimated on 
the HARM INDEX score, which is based on the pharmacologic risk, overdose 
detectability, overdosing range and the type of hospital unit. According to this 
score, errors were categorised as minor, significant, and serious. The economic 
value was estimated based on the hypothetical resulting length of stay had the 
error not been avoided, which increases according to error severity, and the 
financial investment for SISS. Results: Overall, 207,025 infusions were analysed 
from the database of 6 ICUs and 8,503 of them were associated with a safety 
alert (4.1%), including 987 errors (0.48%). Applied to one public ICU equipped with 
5 SISS, the model estimates that SISS would prevent 78 errors per year (54 minor, 
12 significant, 12 serious) and avoid 173 days of hospitalisation per year. This 
corresponds to an annual savings of € 139,491 for the hospital (39% and 61% from 
significant and serious errors, respectively). cOnclusiOns: This model demon-
strates the high economic burden of medication errors for French public hospitals 
and the need for CQI. To date, no equivalent evaluation has been conducted in 
France.
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italy, sPain, united KinGdom
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1Hacettepe University, Ankara, Turkey, 2Health Economics and Policy Association, Ankra, Turkey
Objectives: The Human Capital Theory emphasizes investments to the health 
care sector as an important element in achieving and sustaining economic devel-
opment. Investments to health care sector improves macro and micro economic 
outcomes for the whole society. The aim of this study is to calculate the possible 
produced value for a life-time term (VLT) and cost of pre-mature deaths (CPD) 
from the productivity for France, Germany, Italy, Spain, UK (UK). MethOds: Net 
present value (NPV) of the taxes and spending for each year were calculated. For 
calculating NPV in the government perspectives, two modelling approaches were 
combined, human capital modelling based on lives saved and lost productivity, 
and generational accounting, which accounts for a range of other government fis-
cal transfers to citizens. The possible produced value for a life-time term for each 
country were assumed as calculating the total NPV for each country depending 
on the countries life expectancy. CPD for each countries were assumed as the dif-
ference between NPV on the year of life expectancy and each decades as life years 
60, 50, 40, 30, 20, 10. The economic values for the model of each country derived 
from World Bank, OECD, UNESCO or WHO. Results: Possible produced VLT term 
for each country were calculated as US$ 993.347, US$ 629.814, US$ 245.885, US$ 
48.818 and US$ 1.628.957 for France, Germany, Italy, Spain, UK, respectively. CPD per 
person for France were calculated as US$ -1.060.571, US$ -1.148.852, US$ -887.348, 
US$ -551.873, US$ - 224.070 and US$ -10.972 for the life years 10, 20, 30, 40, 50 and 60 
respectively. Although numbers were different, the trend was same for Germany, 
Italy, Spain, UK. cOnclusiOns: However the study was based on a hypothetical 
model that calculated the NPV with the taxes and spending in a life-time term, 
the results of each country were parallel.
PHP121
switcHinG Patients witH Primary antibody deficiencies to Home-
based subcutaneous immunoGlobulin: economic evaluation of an 
interProfessional druG tHeraPy manaGement ProGram
Perraudin C., Bourdin A., Berger J., Bugnon O.
School of pharmaceutical sciences, University of Geneva, University of Lausanne, Lausanne, 
Switzerland
Objectives: Lifelong immunoglobulin G (IgG) replacement is the standard ther-
apy for patients with primary antibody deficiencies. It can be administered either 
intravenously (IVIg) by health care providers in hospital or subcutaneously (SCIg) 
by patients at home. However, self-administration requires patients’ education 
and support over long term to ensure proper adherence and optimal efficacy and 
safety. Every patient who switches to SCIg is proposed by the Policlinique Médicale 
Universitaire (Lausanne, Switzerland) a drug therapy management program with a 
nurse and a community pharmacist including training, coaching and follow-up. 
The aim of the study was to evaluate if switching to SCIg at home including the 
management program was cost-effective compared to IVIg at hospital. MethOds: 
Assuming that both therapies provide similar efficacy, a 3-years cost-minimization 
analysis based on a simulation model was performed from a societal perspective. 
Health care costs (IgG, time of professionals, infusion pumps and disposables) were 
derived from administrative data. Transport and losses of productivity were esti-
mated. One-way sensitivity analyses were performed. Results: Under base case 
assumptions, SCIg at home was estimated at 34960 CHF per patient the first year 
and 30 030 CHF in subsequent years against 34 170 CHF per year for IVIg. The total 
savings for a switch to SCIg at home with the program was 7490 CHF per patient over 
3 years. Results were relatively sensible to the assumptions. cOnclusiOns: Home-
based SCIg therapy including an interprofessional therapy management program 
may be an effective and efficient alternative to hospital for patients with primary 
antibody deficiencies. Additional costs from purchase of equipment and manage-
ment program in the first year were offset by hospital costs avoided in short term. 
Additional studies are ongoing to analyse the retention in the therapy in medium 
term and the impact on quality of life.
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Gender medicine in Germany: wHat is so difficult about its 
imPlementation? - an emPirical study in Germany –
Chase D.P.1, Mitar I.2, Oertelt-Prigione S.3, Hess N.4, Amelung V.E.5
1Institute for Applied Health Services Research, Berlin, Germany, 2Pfizer Pharma GmbH, Berlin, 
Germany, 3Charité Berlin, Berlin, Germany, 4Cardiology Practice, Berlin, Germany, 5Hannover 
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Objectives: Personalized medicine is currently a popular topic in health care 
debates. Yet, the basic differentiation between females and males is hardly found 
in care delivery/health management programs. This study aimed at elucidating 
the opinion of German Statutory Health Insurance (SHI) managers and internal 
specialists regarding gender-specific care in order to understand their percep-
tions on responsibilities and possible implementation opportunities. MethOds: 
Between April and June 2013, a questionnaire on the implementation of gender 
medicine in the current health care landscape was developed. Based on literature 
review and expert consultations, it included open- and closed-ended questions on 
expectations/prioritization, need for action, and implementation of gender medi-
cine. Forty-eight insurance managers of the largest German SHIs, covering over 
95% of the market, and approximately 16,000 physicians of the German Society 
for Internal Medicine (DGIM) were contacted to complete a web-based survey. 
Descriptive analyses, Chi-square tests, and Pearson correlation coefficient were 
used to investigate the research objective. Results: According to both, insurance 
managers (76%) and physicians (60%), gender-specific care is not sufficiently incor-
porated into standard medical care. Respondents claim the responsibility lies with 
the ministry of health, physicians and medical staff, as well as their associations. 
Specifically, more evidence is needed to incorporate gender aspects in treatment 
guidelines, an idea which is well-supported by insurances (65%) and physicians 
(70%). A top-down approach for implementation is preferred by 65% of insurance 
managers and 50% of physicians, whereas fewer participants encourage bottom-
up mechanisms. cOnclusiOns: German SHIs expect a significant governmental 
influence and/or support of self-governing bodies to achieve an incorporation of 
gender medicine into daily practice. Primary responsibility for the integration of 
gender-specific approaches is perceived to lie with physicians. As soon as critical 
hurdles in the medical field will be removed, the positive perception of both partici-
pating parties can be integrated in the implementation process of gender-medicine.
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Objectives: The Human Capital Theory emphasizes investments to the health 
care sector as an important element in achieving and sustaining economic 
development. Investments to health care sector improves macro and micro eco-
nomic outcomes for the whole society. The aim of this study is to calculate the 
possible produced value for a life-time term (VLT) and cost of pre-mature deaths 
(CPD) from the productivity for Turkey where the life expectancies was noted 75 
years. MethOds: Net present value (NPV) of the taxes and spending for each year 
were calculated. For calculating NPV in the government perspectives, two modeling 
approaches were combined, human capital modeling based on lives saved and lost 
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productivity, and generational accounting, which accounts for a range of other gov-
ernment fiscal transfers to citizens. The possible produced value for a life-time term 
was assumed as calculating the total NPV depending on the life expectancy. CPD 
was assumed as the difference between NPV on the year of life expectancy and each 
decades as life years 50, 40, 30, 20, 10 and new born. The economic values for the 
model were derived from World Bank, OECD, UNESCO or WHO. Results: Possible 
produced value for a life-time term for Turkey was calculated as US$ 483.298. Cost 
of pre-mature death per person was calculated as US$ - 102.064, US$ - 271.716, US$ 
-441.679, US$ -583.726, US$ - 518.753,14 and US$ - 483.986 for the life years new born, 
10, 20, 30, 40 and 50 respectively. cOnclusiOns: However the study was based 
on a hypothetical model that calculated the NPV with the taxes and spending in a 
life-time term, cost of premature death was calculated as the highest in early ages 
and was decreasing up to the retirement age. The results may be reference for the 
decision makers. Health policy makers may improve the access to the treatments 
in the early life years for the possible increased cost of premature deaths in Turkey.
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exPosure to Potential druG-druG interactions in teacHinG HosPital 
of soutH Punjab, PaKistan
Khan H.M.S.1, Butt H.1, Shah N.H.2
1Islamia University Bahawalpur, The Islamia University of Bahawalpur, Pakistan, 2Bahauddin 
Zakarya University, Multan, Pakistan
Objectives: Drug-drug interaction is a common error in poly-medication and con-
tributes a major part in adverse drug reactions. The aim of the present study was to 
evaluate the percentage of potential drug-drug interactions in the prescription in the 
region of South Punjab Pakistan prescribed by the medical practitioner MethOds: A 
total of 100 prescriptions were included in this study. Institution based retrospective 
study was performed in Nishter Hospital Multan, Pakistan, the 3rd oldest medical 
institution of Pakistan, which has a capacity of 1800 beds and having a best facil-
ity to hold a large number of emergencies at a time. Prescriptions were collected 
to see the Drug - Drug interactions and compared with the standard reference of 
important DDI’s. The potential drug-drug interactions were categorized according 
to their severity, effect and mechanism. Results: The study showed that among 
100 prescriptions (543 medicines), 41% of prescriptions have potential DDI’s. Mostly 
prescribed drugs were the antibiotics (38%), and the drugs belonging to class analge-
sic were found to contribute mostly in drug-drug interactions (26.50%). The survey 
showed the total of 71 interactions and their severity level accounting as major 
(20.10%), moderate (63.4%) and minor (15.90). The mechanism by which the drugs 
interact with one another showed that there were pharmacokinetic (60.5%), pharma-
codynamic (38.6%) and few of them interact by the mechanism which was not speci-
fied in the available literature (0.9%). cOnclusiOns: Drug-drug interactions occur 
in poly-medication and need to be evaluated and monitored for the positive impact 
on the medication use system and improvement of quality of patient care. A clini-
cal pharmacist with its accurate knowledge of drug, their effect on human organs 
and their interaction with other can monitor and manage these drug interactions.
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and mexico
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Objectives: The Human Capital Theory emphasizes investments to the health care 
sector as an important element in achieving and sustaining economic development. 
Investments to health care sector improves macro and micro economic outcomes 
for the whole society. The aim of this study is to calculate the possible produced 
value for a life-time term (VLT) and cost of pre-mature deaths (CPD) from the pro-
ductivity for Argentina, Brazil and Mexico. MethOds: Net present value (NPV) of 
the taxes and spending for each year were calculated. For calculating NPV in the 
government perspectives, two modelling approaches were combined, human capital 
modelling based on lives saved and lost productivity, and generational accounting, 
which accounts for a range of other government fiscal transfers to citizens. The 
possible produced value for a life-time term for each country were assumed as cal-
culating the total NPV for each country depending on the countries life expectancy. 
CPD for each countries were assumed as the difference between NPV on the year 
of life expectancy and each decades as life years 60, 50, 40, 30, 20, 10. The economic 
values for the model of each country derived from World Bank, OECD, UNESCO or 
WHO. Discount rate and inflation for wages were taken as 3% per year for all coun-
tries. Results: Possible produced VLT for each country were calculated as US $ 
716.945, US$ 663.129 and US$ 653.598 for Argentina, Brazil and Mexico, respectively. 
CPD per person for Argentina were calculated as US$ -666.234, US$ -657.861, US$ 
-512.554, US$ -338.675, US$ - 164.722 and US$ -24.615 for the life years 10, 20, 30, 40, 
50 and 60 respectively. The trend was same for Brazil and Mexico. cOnclusiOns: 
However the study was based on a hypothetical model that calculated the NPV with 
the taxes and spending in a life-time term, the results of each country were parallel.
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community PHarmacist PercePtions of Generic medicines: a survey 
in teHran
Mehralian G.1, Noee F.2, Yousefi N.1, Peiravian F.1
1Shahid Beheshti University of Medical Sciences, School of Pharmacy, Tehran, Iran, 2Azad 
University, Tehran, Iran
Pharmaceutical expenditure as has been increasingly grown during the last decades 
so that policy makers have paid more and more attention to develop strategies 
to deal with this challenging issue. Pharmacists play an important role in health 
continuum to implement such strategies through dispensing and delivering generic 
medicines to consumers. So, the main objective of this study was to explore the per-
ception of Iranian pharmacists regarding generic substitution, and also to explore 
how Iranian pharmacists think about patients’ role, physicians’ role and government 
role in generic substitution. A cross sectional descriptive study involving the entire 
population of Tehran community pharmacies (n = 2000) was performed using a 
self-administrated anonymous questionnaire. A total of 1205 questionnaires were 
returned indicating a response rate of 60%. Regarding to the first section, 62% of 
participants agreed that pharmacists should be given right to generic substitu-
tion, and 45% viewed that the generic medicine are bioequivalent with brand ones. 
Majority of the respondents (73.6%) stated that, they do substitution once generic 
medicine is available. However, they think that patients, physicians and government 
have important role in generic substitution. More than half (75.5%) of pharmacists 
believed physicians’ prescription behavior highly influenced by the marketing 
and promotion activities of foreign companies. 93% of respondents pointed to full 
coverage of generic medicines by providers as a strategy to generic substitution. 
Summary, evidences indicated that Iranian pharmacists have good insights regard-
ing implementation and promotion of generic substitution strategy.
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buildinG a “HiGH-alert/HiGH risK medications reminder system” to 
imProve Patient safety
Kao L.C.
Mackay Memorial Hospital, Taipei, Taiwan
Objectives: This paper was aimed to introduce how we developed a “high-alert/
high risk medications reminder system” operated in the computer system to 
improve medication safety in our hospital. MethOds: This reminder system was 
designed in a 2,400-bed health institute with 2,000 nurses, consisting of 12 nursing 
divisions and 75 units. The new module was added to the current BCMA system with 
VB. net. The functions of this computer system include seven steps. Results: A 
satisfaction and cognition survey on the application of the new, computerized “high-
alert/ high risk medications reminder system” was done to MICU nurses (N= 36). The 
survey response rate was 100%. The results showed high rate of positive support 
on the new system due to easy to access and easy to learn. The satisfactory rate 
comparing the old paper form system and the new computer system was 62.8% vs. 
96.1%. More importantly, the “high-alert/high risk medications reminder system” 
appeared to reduce the administration error rate from 5 cases in 2011 to 0 cases 
in 2012. cOnclusiOns: Our early experience showed that an efficient and user-
friendly “High-Alert/High Risk Medications Reminder System” could be helpful for 
medical staffs to improve medication safety although a longer follow-up time to 
evaluate the efficacy of the computerized system is still needed before a final con-
clusion can be established. In addition, we are also keen to investigate whether this 
system could reduce the waste of time, expenditure, and manpower in a medical 
center in our future study.
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cost-effectiveness of telemedicine: lessons to learn from an 
international review
Bongiovanni-Delarozière I.1, Le Goff-Pronost M.2, Rapp T.3
1French National Authority of Health (HAS), Saint Denis La Plaine, France, 2Telecom Bretagne, 
Brest, Brittany, France, 3University of Paris Descartes, Paris, France
Objectives: At the global level the large deployment of telemedicine raises needs 
for cost-effectiveness evaluations. The objective of this literature review is to explore 
to what extend telemedicine innovations that were implemented in many countries 
were cost-effective. Specifically, we explore whether the model used to evaluate the 
cost-effectiveness can be adapted to the evaluation of telemedicine technologies. 
So, what answers can a review of the international literature relating to the med-
ico-economic evaluation of telemedicine provide? MethOds: Following analytical 
reading of 286 articles published between 2000 and 2013, 74 studies that imple-
mented economic evaluation of telemedicine are analysed. Three axis of analysis 
are considered: the act concerned by the telemedicine intervention, the medical 
speciality, the economic evaluation method implemented. Results: The descrip-
tive analysis showed significant heterogeneity in studies characteristics: economic 
analysis method, telemedicine applications, medical specialities, and organisational 
practices. The qualitative analysis underlines that most studies face methodological 
issues and provide reduced evidence of the economic impact of the telemedicine 
interventions. The telemedicine technologies are too individualised (by the context 
and the organisation) to be evaluated using the standards of cost-effectiveness 
analysis. cOnclusiOns: This literature review did not allow proposing a classifica-
tion for telemedicine practices identified as efficient, depending on the strategies 
compared, field of application or speciality, types of telemedicine or an organisation 
of care model. Despite all this, one focus can be the management of chronic diseases 
that remains a central topic at the international level. The increase in the number 
of medical specialities or fields of application concerned with telemedicine and 
the increased volume of activity necessitate the dissemination of methodological 
recommendations to promote the coherent development of economic evaluations. 
Our literature review shows that there is need to develop innovative methods to 
assess the cost-effectiveness of telemedicine technologies.
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assessment of validity of an indicator module in identification of 
adverse druG events in Patients of medicine dePartment
Mallayasamy S., Shravya J., Mehta A., Vilakkathala R.
Manipal University, Manipal, India
Objectives: An indicator is a clue that helps a health care organization to iden-
tify adverse drug events and assess the overall harm that occurs from medical 
care within that organization. The main aim of the study was to investigate use 
of an indicator list for identification of adverse events in the health care setting 
studied. MethOds: The study was a prospective observational study in a tertiary 
care teaching hospital. The study mainly involves the review of medical records of 
patients in general medicine department who were admitted due to drug related 
problems with the help of trigger tool. When the presence of indicator is identified, 
those cases were thoroughly scrutinized to identify adverse drug events and confirm 
